Oncology

A Breast-Cancer Warning Is Hiding in Aggregated Data
A JAMA Network Open study found rising invasive breast-cancer incidence among Asian American, Native Hawaiian and Pacific Islander women, with sharp increases in some early-onset and distant-stage disease groups. The message is political: aggregated categories can hide urgent risk.

Cancer Pharmacogenomics Exposes an Ancestry Gap in Routine Testing

Biomarker Testing Is Rising, But Eligibility Still Gets Lost

Colon Cancer MRD Testing Is Nearing the Access Threshold

Breast Cancer Blood Tests Could Bring Treatment Decisions Earlier

Lung Cancer Screening Now Has a Diagnostic Bottleneck

Liquid Biopsy Turns Precision Oncology Into an NHS Delivery Test

Molecular Testing Is Europe’s Real Precision Oncology Infrastructure

Cancer Approval Is No Longer Enough

Europe’s Cancer Inequality Map Becomes a Performance Test
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
